These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15617024)

  • 1. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
    Chu AJ
    Cell Biochem Funct; 2006; 24(2):173-92. PubMed ID: 15617024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor mediates inflammation.
    Chu AJ
    Arch Biochem Biophys; 2005 Aug; 440(2):123-32. PubMed ID: 16036212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
    Mackman N; Tilley RE; Key NS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
    Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of tissue factor in cardiovascular disease.
    Jude B; Zawadzki C; Susen S; Corseaux D
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.
    Chu AJ
    Front Biosci; 2006 Jan; 11():256-71. PubMed ID: 16146730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.
    Chu AJ
    Inflamm Allergy Drug Targets; 2011 Feb; 10(1):13-8. PubMed ID: 21184651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor: beyond coagulation in the cardiovascular system.
    Breitenstein A; Camici GG; Tanner FC
    Clin Sci (Lond); 2009 Oct; 118(3):159-72. PubMed ID: 19845509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?
    Cimmino G; D'Amico C; Vaccaro V; D'Anna M; Golino P
    Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):517-23. PubMed ID: 21517734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tissue factor as an antithrombotic strategy.
    Golino P; Cimmino G
    Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
    Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
    Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
    Chu AJ; Wang ZG; Fox MJ
    Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor: a mini-review.
    Daubie V; Pochet R; Houard S; Philippart P
    J Tissue Eng Regen Med; 2007; 1(3):161-9. PubMed ID: 18038407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.
    Mitroulis I; Kambas K; Anyfanti P; Doumas M; Ritis K
    Expert Opin Ther Targets; 2011 Jan; 15(1):75-89. PubMed ID: 21062231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
    Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
    Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
    Hedner U; Erhardtsen E
    Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
    Steffel J; Lüscher TF; Tanner FC
    Circulation; 2006 Feb; 113(5):722-31. PubMed ID: 16461845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between inflammation and thrombosis.
    Esmon CT
    Maturitas; 2004 Apr; 47(4):305-14. PubMed ID: 15063484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.